IP Library Granted Patent US 7,217,739
Granted Patent B2
US 7,217,739 · App. 11/069,292 · Granted May 15, 2007

Method for inducing cell death with carbonyl scavengers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,217,739
App. No.
11/069,292
Granted
May 15, 2007
Kind
B2
Abstract

Carbonyl scavengers, which have been recognized for their ability to react with reactive carbonyl species, have been implicated as agents that can accelerate or induce the death of abnormal cells without having a parallel effect on normal cells. As such, they are useful therapeutic agents in cases where the acceleration or induction of cell death is desirable, such as in cells where the normal apoptotic pathways have been disrupted and where hyperproliferative cell growth occurs.

Claims (10)

1. A method for inducing or accelerating cell death in an abnormal cell, wherein the abnormal cell is a melanoma, a squamous carcinoma cell, an adenocarcinoma cell, an epithelial carcinoma cell, or a premalignant keratinocyte, comprising administering to said abnormal cell an amount of a carbonyl scavenger sufficient to induce or to accelerate death of said abnormal cell, wherein said carbonyl scavenger is D-penicillamine, amino guanidine, or 3 methyl-3 ethyl cysteine(MEC).

2. The method of claim 1 , comprising administering said carbonyl scavenger topically.

3. The method of claim 1 , further comprising administering said carbonyl scavenger to a human being.

4. The method of claim 1 , wherein said abnormal cell is a melanoma cell.

5. The method of claim 1 , wherein said abnormal cell is a squamous cell carcinoma cell.

6. The method of claim 1 , wherein said abnormal cell is an epithelial carcinoma cell.

7. The method of claim 1 , wherein said abnormal cell is an adenocarcinoma cell.

8. The method of claim 1 , wherein said carbonyl scavenger is penicillamine.

9. The method of claim 1 , wherein said carbonyl scavenger is amino guanidine.

10. The method of claim 1 , wherein said carbonyl scavenger is 3 methyl-3 ethyl cystien (MEC) methyl, ethyl cysteine.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: BLUE TORCH FINANCE LLC
To: NIADYNE, INC.
Reel/Frame 057535/0177 →
RELEASE OF COLLATERAL ASSIGNMENT (PATENTS) Recorded Jun 17, 2019
From: DEM HOLDINGS, L.P.
To: NIADYNE, INC.
Reel/Frame 049485/0895 →
ASSIGNMENT FOR SECURITY -- PATENTS Recorded Jun 17, 2019
From: NIADYNE, INC.
To: BLUE TORCH FINANCE, LLC, AS COLLATERAL AGENT
Reel/Frame 049494/0669 →
RELEASE OF SECURITY INTEREST Recorded Jun 12, 2019
From: DEM HOLDINGS, L.P., AS AGENT FOR LENDERS
To: NIADYNE, INC.
Reel/Frame 049451/0560 →
SECURITY INTEREST Recorded Oct 20, 2016
From: NIADYNE, INC.
To: DEM HOLDINGS, L.P.
Reel/Frame 040075/0342 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2005
From: WONDRAK, GEORG T.; JACOBSON, MYRON K.; JACOBSON, ELAINE L.
To: ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERISTY OF ARIZONA
Reel/Frame 016020/0419 →